Christoph Röllig

47PUBLICATIONS
304CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMedical virologyNgā taonga Māori nō mua (Māori artefacts)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Mar 20, 2026
Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Maximilian Alexander Röhnert, Anna Seifert, Karolin Trautmann-Grill

|Feb 16, 2026
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow.

Jonas Schadt, Malte von Bonin, Uta Oelschlägel

|Jan 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study.

Alberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng

|Dec 08, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.

Anne Sophie Platzbecker, Julia-Annabell Georgi, Jan Moritz Middeke

Pageof 8